A Multicenter, Open-Label Study of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis
Phase of Trial: Phase III
Latest Information Update: 26 Jul 2017
At a glance
- Drugs Adalimumab (Primary)
- Indications Pustular psoriasis
- Focus Therapeutic Use
- Sponsors AbbVie
- 21 Jul 2017 Status changed from active, no longer recruiting to completed.
- 31 May 2016 Status changed from recruiting to active, no longer recruiting.
- 29 Aug 2015 New trial record